Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy...
Date First Received: January 16, 2001
Last Updated: June 23, 2005
Verified by: National Center for Research Resources (NCRR), December 2003
Clinical Trial Phase: Phase 2 | Start Date:
Overall Status: Completed
Brief Summary
Official Title: “Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide”
Condition Keyword(s):
Intervention(s):
Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
Study Type: Interventional
Study Design: Treatment, Non-Randomized
Intervention(s) in this Clinical Trial
- Drug: metoclopramide
Criteria for Participation in this Clinical Trial
Inclusion:
- Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: N/A
Maximum Age for this Clinical Trial: 1 Month
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Sponsor Information
Lead Sponsor: National Center for Research Resources (NCRR)
Additional Information
Information obtained from ClinicalTrials.gov on July 02, 2009
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00008736
Study ID Number: NCRR-M01RR00240-1724
ClinicalTrials.gov Identifier: NCT00008736
Health Authority: United States: Federal Government
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
